NCT06869629 Omission of Axillary Lymph Node Dissection in Case of Tumor Spread to Lymph Nodes in the Armpit in Breast Cancer Status NOT_YET_RECRUITING Phase NA
NCT06866093 The Study is Observational and Retrospective: Lifestyle, BMI and Activity Physical. Status ACTIVE_NOT_RECRUITING Phase N/A
NCT06865131 Efficacy Study With StrataXRT for the Prophylaxis of Radiation Dermatitis in Adjuvant Breast Radiation Treatment in Large Breasted Women Using a Prone Technique Status ACTIVE_NOT_RECRUITING Phase NA
NCT06860217 Robotic Nipple Sparing Mastectomy with Immediate Reconstruction Status NOT_YET_RECRUITING Phase NA
NCT06858449 Resistance Training and Post Workout Protein to Improve Body Composition During Neoadjuvant Chemotherapy for Breast Cancer Status RECRUITING Phase NA
NCT06857747 Disitamab Vedotin in Combination with Metronomic Chemotherapy in Advanced HER2-expressing Breast Cancer. Status NOT_YET_RECRUITING Phase NA
NCT06852560 A Trial Assessing Feasibility of Allostatic Load Biomarkers and CVD Risk Among Black Breast Cancer Survivors Status WITHDRAWN Phase NA
NCT06851442 Clinical Trial of Evaluating TQB3912 Tablets Combined With Fulvestrant Injection±TQB3616 Capsules for Locally Advanced or Metastatic Hormone Receptor(HR)-Positive and Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Breast Cancer Status TERMINATED Phase PHASE1/PHASE2
NCT06846099 A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Efficacy and Indications of RP903 Status COMPLETED Phase PHASE1
NCT06842472 PD-L1 Inhibitor + RT ± Ursodeoxycholic Acid in Recurrent/Metastatic HER2-Neg Breast Cancer Status NOT_YET_RECRUITING Phase PHASE2
NCT06840483 Study of Zelenectide Pevedotin in Participants With Advanced Breast Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT06839001 CRYoablation for Small Tumors As Local Treatment - SIX Trial Status RECRUITING Phase PHASE3
NCT06837701 The True Face of the Pyramid; Physical Activity Level and Cardiovascular Risk in Patients With Breast Cancer Status COMPLETED Phase N/A
NCT06835348 An Observational, Multicenter Study Evaluating the Safety of ReAl-lifePertuzumab and Trastuzumab Fixed Dose Combination: the RAPID Study Status COMPLETED Phase N/A
NCT06833502 Phase II Study of Systemic Screening in Pathologic Node Positive Breast Cancer Status RECRUITING Phase PHASE2